Elena Parvez
Overview
Explore the profile of Elena Parvez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eom A, Kirkwood D, Pond G, Hodgson N, Doumouras A, Bogach J, et al.
Radiother Oncol
. 2025 Feb;
205:110774.
PMID: 39894258
Introduction: Radiation therapy (RT) is an essential component of treatment for breast cancer (BC), and while indications and delivery techniques evolve, inequities in access remain. Immigrant women face barriers navigating...
2.
McKechnie T, Talwar G, Grewal S, Wang A, Eskicioglu C, Parvez E
Melanoma Res
. 2024 Sep;
34(6):475-486.
PMID: 39264579
Statin use may decrease recurrence and improve survival in patients with melanoma. In this systematic review and meta-analysis, we examine the current body of literature concerning the use of statins...
3.
McKechnie T, Brown Z, Lovrics O, Yang S, Kazi T, Eskicioglu C, et al.
Clin Breast Cancer
. 2024 Jan;
24(3):e103-e115.
PMID: 38296737
Pre-clinical studies in triple negative breast cancer (TNBC) suggest that statins may inhibit cell proliferation, promote cell-cycle arrest, induce apoptosis, change the tumor microenvironment, and improve effectiveness of other therapies....
4.
Briere R, Emond M, Benhamed A, Blanchard P, Golbon B, Shellenberger J, et al.
Can J Surg
. 2024 Jan;
66(6 Suppl 1):S54-S136.
PMID: 38173057
No abstract available.
5.
Parvez E, Chu M, Kirkwood D, Doumouras A, Levine M, Bogach J
Breast Cancer Res Treat
. 2023 Apr;
199(3):553-563.
PMID: 37081175
Purpose: Immigrants are susceptible to marginalization due to social isolation, economic disadvantage and systemic bias. Our goal was to compare symptom burden between immigrant and long-term resident women undergoing breast...
6.
Lovrics O, Tao B, Parvez E
Curr Oncol
. 2023 Mar;
30(3):3102-3110.
PMID: 36975448
Landmark trials (Z0011 and AMAROS) have demonstrated that axillary lymph node dissection (ALND) can be safely omitted in patients with breast cancer and 1-2 positive sentinel nodes. Extrapolating from these...
7.
Parvez E, Khosrow-Khavar F, Dumitra T, Nessim C, Bernard-Bedard E, Rivard J, et al.
Ann Surg Oncol
. 2022 Oct;
30(2):1195-1205.
PMID: 36282456
Background: Following publication of the MSLT-II trial showing no survival benefit of completion lymphadenectomy (CLND) in patients with melanoma sentinel lymph node (SLN) metastases, it is expected that practice patterns...
8.
Parvez E, Martel K, Morency D, Dumitra S, Meguerditchian A, Dionisopoulos T, et al.
Clin Breast Cancer
. 2020 Apr;
20(4):353-358.
PMID: 32305298
Background: Nipple-sparing mastectomy (NSM) remains controversial in patients with high-risk breast cancer. The objective of this study was to assess surgical and oncologic outcomes of NSM and to evaluate associations...
9.
Morency D, Dumitra S, Parvez E, Martel K, Basik M, Robidoux A, et al.
Ann Surg Oncol
. 2019 Oct;
26(13):4337-4345.
PMID: 31605348
Background: The sentinel node biopsy following neoadjuvant chemotherapy (SN FNAC) study has shown that in node-positive (N+) breast cancer, sentinel node biopsy (SNB) can be performed following neoadjuvant chemotherapy (NAC),...
10.
Parvez E, Cornacchi S, Fu E, Hodgson N, Farrokhyar F, Reid S, et al.
Am J Surg
. 2018 Jul;
216(6):1160-1165.
PMID: 30005808
Introduction: Radioguided seed localization (RSL) is an alternative technique to wire-guided localization (WL) for localizing non-palpable breast lesions for breast conserving surgery. The purpose of this study was to assess...